PharmaShots | Incisive News in 3 Shots

Subscribe Now

Regdanvimab

AstraZeneca and Moderna Present Results of AZD8601 in P-IIa EPICCURE Trial for the Treatment of Heart Failure at AHA 2021

AstraZeneca and Moderna Present Results of AZD8601 in P-IIa EPICCURE Trial for the Treatment of Heart Failure at AHA 2021

November 16, 2021

Celltrion's Regdanvimab (CT-P59) Receives the ANVISA's EUA for the Treatment of COVID-19 in Brazil

Celltrion's Regdanvimab (CT-P59) Receives the ANVISA's EUA for the Treatment of COVID-19 in Brazil

August 13, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us